Provided by Tiger Trade Technology Pte. Ltd.

United Community Banks

34.11
-0.7300-2.10%
Pre-market: 33.84-0.2700-0.79%04:08 EDT
Volume:700.28K
Turnover:24.01M
Market Cap:4.11B
PE:11.16
High:34.91
Open:34.73
Low:34.00
Close:34.84
52wk High:37.18
52wk Low:28.65
Shares:120.58M
Float Shares:119.62M
Volume Ratio:1.23
T/O Rate:0.59%
Dividend:1
Dividend Rate:2.93%
EPS(TTM):3.06
EPS(LYR):2.62
ROE:10.27%
ROA:1.32%
PB:1.10
PE(LYR):13.00

Loading ...

United Community Banks - to Sell Equipment Finance Business to Wafra for $1.9 Bln in Cash

THOMSON REUTERS
·
Jun 12

United Community Banks - Navitas Executive Team and Employees to Remain After Sale to Wafra

THOMSON REUTERS
·
Jun 12

United Community Banks: Expects Impact on EPS to Be Offset as Excess Capital Is Deployed Over Time, While Lowering Risk Profile of Franchise

THOMSON REUTERS
·
Jun 12

United Community Banks - Deal to Result in $109 Mln One-Time Pre-Tax Earnings Benefit and 3% Tangible Book Value Accretion

THOMSON REUTERS
·
Jun 12

United Community Banks - Deal Expected to Generate 145 Basis Points of Cet1 Capital

THOMSON REUTERS
·
Jun 12

UCB SA (0NZT) Receives a Buy from UBS

TIPRANKS
·
Jun 09

UCB, Biogen announce dapirolizumab pegol data at EULAR

TIPRANKS
·
Jun 04

Biogen, UCB publishes full results from PHOENYCS GO clinical trial in The Lancet

TIPRANKS
·
Jun 01

UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus

GlobeNewswire
·
Jun 01

United Community Banks Shareholders Back Directors and Governance

TIPRANKS
·
May 15

United Community Banks shareholders approve PwC as auditor for 2026

Reuters
·
May 15

United Community Banks Keeps Quarterly Dividend at $0.25 a Share, Payable July 3 to Holders of Record June 15

MT Newswires Live
·
May 15

Press Release: United Community Banks, Inc. Announces Quarterly Cash Dividend on Common Stock

Dow Jones
·
May 15

United Community Banks management to meet with Piper Sandler

TIPRANKS
·
May 14

United Community Banks Q1 FY26 net income rises 18% to $84.3 million

Reuters
·
May 07

Barclays Reaffirms Their Buy Rating on UCB SA (0NZT)

TIPRANKS
·
May 05

Edding Genor’s GB261 Gains Momentum as UCB Moves to Acquire Licensee Candid Therapeutics

TIPRANKS
·
May 04

EDDING GENOR (06998): Candid Therapeutics Acquired by UCB with $2 Billion Upfront Payment

Stock News
·
May 04

Cullinan jumps after UCB acquires Candid Therapeutics

TIPRANKS
·
May 04

Press Release: UCB to Acquire Candid Therapeutics, Building Upon Its Existing Immunology Pipeline With Novel T-cell Engagers

Dow Jones
·
May 04